Oncoinvent ASA (ONCIN)

Currency in NOK
69.00
-2.00(-2.82%)
Closed·
Advertisement
ONCIN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
67.0074.00
52 wk Range
40.10144.00
Key Statistics
Prev. Close
69
Open
74
Day's Range
67-74
52 wk Range
40.1-144
Volume
9.05K
Average Volume (3m)
40.74K
1-Year Change
11.2903%
Book Value / Share
18.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONCIN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
111.00
Upside
+60.87%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Oncoinvent ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 111.00
(+60.87% Upside)

Earnings

Latest Release
27/08/2026
EPS / Forecast
-15.20 / --
Revenue / Forecast
8.2M / --
EPS Revisions
Last 90 days

Compare ONCIN to Peers and Sector

Metrics to compare
ONCIN
Peers
Sector
Relationship
P/E Ratio
−2.5x−1.9x−0.2x
PEG Ratio
−0.040.010.00
Price/Book
5.2x2.8x2.6x
Price / LTM Sales
17.4x9.6x2.8x
Upside (Analyst Target)
60.9%562.4%61.2%
Fair Value Upside
Unlock30.0%9.7%Unlock

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. Oncoinvent ASA is based in Oslo, Norway.

Employees
42
Market
Norway

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
4.29M70.08%296.33M
Public Companies & Retail Investors
1.83M29.92%126.53M
Total
6.13M100.00%422.86M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Skandinaviska Enskilda Banken AB (publ)13.62%834,89057,607
Linc AB12.21%748,25051,629

People Also Watch

35.45
NSKOG
-2.34%
46.25
OKEA
+0.98%
19.86
MGN
-3.83%
25.50
XPLRA
-2.86%
17.32
ARCHA
+1.41%

FAQ

What Is the Oncoinvent (Oslo: ONCIN) Share Price Today?

The Oncoinvent stock price today is 69.00 NOK.

What Stock Exchange Does Oncoinvent (ONCIN) Trade On?

Oncoinvent is listed and trades on the Oslo Stock Exchange.

What Is the Ticker (Stock Symbol) for Oncoinvent?

The stock symbol (also called a 'ticker') for Oncoinvent is "ONCIN."

What Is the Current Oncoinvent Market Capitalisation?

As of today, Oncoinvent (Oslo: ONCIN) market cap is 422.86M NOK.

What Is Oncoinvent's (ONCIN) Earnings Per Share (TTM)?

The Oncoinvent EPS is currently -57.11 (Trailing Twelve Months).

When Is the Next Oncoinvent Earnings Date?

Oncoinvent's next earnings report will be released on 17/11/2026.

Is ONCIN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Oncoinvent moving averages and other technical indicators, the daily buy/sell signal for ONCIN stock is Strong Buy.

How Many Times Has Oncoinvent Stock Split?

Oncoinvent has split 4 times. (See the ONCIN stock split history page for full effective split date and price information.)

How Many Employees Does Oncoinvent Have?

Oncoinvent has 42 employees, based on their latest Companies House report.

What is the current trading status of Oncoinvent (Oslo: ONCIN)?

As of 15/11/2026, Oncoinvent (ONCIN) is trading at a share price of 69.00 NOK, with a previous close of 69.00 NOK. The stock has fluctuated within a day range of 67.00 NOK to 74.00 NOK, while its 52-week range spans from 40.10 NOK to 144.00 NOK.

What Is Oncoinvent (ONCIN) Price Target According to Analysts?

The average 12-month price target for Oncoinvent is 111.00 NOK, with a high estimate of 112 NOK and a low estimate of 110 NOK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +60.87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.